This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Creager, M. A. Articles by Stamler, J. S. Search for Related Content PubMed PubMed Citation Articles by Creager, M. A. Articles by Stamler, J. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLCYSTEINE NITRIC OXIDE NITROGLYCERIN

(Hypertension. 1997;29:668-672.)
© 1997 American Heart Association, Inc.

Articles

N-Acetylcysteine Does Not Influence the Activity of Endothelium-Derived Relaxing Factor In Vivo

Mark A. Creager; Mary-Anne Roddy; Kimberly Boles; Jonathan S. Stamler

the Vascular Medicine and Atherosclerosis Unit of the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

Nitric oxide forms complexes with an array of biomolecular carriers that retain biological activity. This reactivity of nitric oxide in physiological systems has led to some dispute as to whether endothelium-derived relaxing factor is nitric oxide or a closely related adduct thereof, such as a nitrosothiol. In vitro bioassays used to address this question are limited by the exclusion of biological thiols that are requisite for nitrosothiol formation. Thus, the purpose of this study was to obtain insight into the identity of endothelium-derived relaxing factor in vivo. We reasoned that if endothelium-derived relaxing factor is nitric oxide, infusion of physiological concentrations of thiol would potentiate its bioactivity by analogy with effects seen in vitro, whereas nitrosothiol would be resistant to such modulation. We used venous-occlusion plethysmography to study forearm blood flow in normal subjects. Methacholine (0.3 to 10 µg/min) and nitroglycerin (1 to 30 µg/min) were infused via the brachial artery to elicit endothelium-dependent and endothelium-independent vasodilation, respectively. Dose-response determinations were made for each drug before and after an intra-arterial infusion of the reduced thiol, N-acetylcysteine, at rates estimated to achieve a physiological concentration of 1 mmol/L. Methacholine increased forearm blood flow in a dose-dependent manner. Infusion of N-acetylcysteine did not change the sensitivity (ED₅₀, 1.7 versus 1.7 µg/min, P=NS) or maximal response to methacholine. In contrast, thiol increased the sensitivity to nitroglycerin (ED₅₀, 4.7 versus 2.8 µg/min, P<.01). Thus, conflicting with reports in vitro, thiol does not modulate endothelium-derived relaxing factor responses in vivo. These data indicate that sulfhydryl groups are not a limiting factor for endothelium-derived relaxing factor responses in forearm resistance vessels in normal humans and are in keeping with reports that nitrosothiol contributes to endothelium-derived relaxing factor bioactivity in plasma and vascular smooth muscle. Potentiation of the effects of nitroglycerin by N-acetylcysteine can be attributed to its enhanced biotransformation to an endothelium-derived relaxing factor equivalent, such as nitrosothiol. These observations support the notion of an equilibrium between nitric oxide and nitrosothiol in biological systems that may be influenced by redox state.

Key Words: endothelium-derived relaxing factor • nitric oxide • N-acetylcysteine • N^G-monomethyl-L-arginine • forearm blood flow

This article has been cited by other articles:

				H. D. Spapen, M. W. Diltoer, D. N. Nguyen, I. Hendrickx, and L. P. Huyghens Effects of N-acetylcysteine on Microalbuminuria and Organ Failure in Acute Severe Sepsis: Results of a Pilot Study Chest, April 1, 2005; 127(4): 1413 - 1419. [Abstract] [Full Text] [PDF]

				M. S. Crane, R. Ollosson, K. P. Moore, A. G. Rossi, and I. L. Megson Novel Role for Low Molecular Weight Plasma Thiols in Nitric Oxide-mediated Control of Platelet Function J. Biol. Chem., November 27, 2002; 277(49): 46858 - 46863. [Abstract] [Full Text] [PDF]

				N. P. Andrews, A. Prasad, and A. A. Quyyumi N-acetylcysteine improves coronary and peripheral vascular function J. Am. Coll. Cardiol., January 1, 2001; 37(1): 117 - 123. [Abstract] [Full Text] [PDF]

				P. M. Kanani, C. A. Sinkey, R. L. Browning, M. Allaman, H. R. Knapp, and W. G. Haynes Role of Oxidant Stress in Endothelial Dysfunction Produced by Experimental Hyperhomocyst(e)inemia in Humans Circulation, September 14, 1999; 100(11): 1161 - 1168. [Abstract] [Full Text] [PDF]

				A. Prasad, N. P. Andrews, F. A. Padder, M. Husain, and A. A. Quyyumi Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability J. Am. Coll. Cardiol., August 1, 1999; 34(2): 507 - 514. [Abstract] [Full Text] [PDF]